Chancellor announces 22.6bn cash injection for health service in budget
The NHS will receive a £22.6bn funding boost aiming to improve care and reduce waiting lists, but experts warn patients may not see immediate benefits.
Private healthcare boom fuelled by NHS waiting lists
The UK's private healthcare market value reached £12.4 billion due to NHS waiting list pressures.
NHS spending on private healthcare increased significantly to alleviate care backlogs.
Chancellor announces 22.6bn cash injection for health service in budget
The NHS will receive a £22.6bn funding boost aiming to improve care and reduce waiting lists, but experts warn patients may not see immediate benefits.
Private healthcare boom fuelled by NHS waiting lists
The UK's private healthcare market value reached £12.4 billion due to NHS waiting list pressures.
NHS spending on private healthcare increased significantly to alleviate care backlogs.
Scottish ministers mismanaging NHS', say opposition, as huge hourly rates revealed
Scottish opposition leaders criticize NHS management due to excessive spending on temporary psychiatrists, calling for better recruitment and retention strategies.
South east London spends least amount of money on prescriptions in England
Prescription spending differs across regions, influenced by demographic factors and healthcare choices.
London's unique population significantly lowers prescription costs compared to the national average.
Depression too often gets deemed 'hard to treat' when medication falls short
Depression treatment requires a variety of approaches
Increased depression during COVID-19 led to mental health challenges
Despite their prevalence, arthritis, neck, and back pain receive few research dollars - Harvard Gazette
Musculoskeletal diseases are a leading cause of disability and healthcare spending in the U.S.
Federal funding for musculoskeletal diseases is significantly lower than the disease burden suggests.
What to know as weight-loss drugs get popular in the U.S.
Obesity drugs like Ozempic are in high demand in the US, with the market predicted to exceed $150 billion a year within a decade.
The boom in demand for these drugs raises concerns about long-term health effects and increased healthcare spending.